The global mental health pharmaceutical industry was estimated at $80.5 billion in 2010. By 2015, this market is likely to reach $88.3 billion, at a compound annual growth rate (CAGR) of 1.9% from 2010 to 2015.
Learn about the current state of pharmaceutical markets, and new drug development in the mental health segment, existing products on the market, and a detailed analysis of the competitive environments, including new potential markets and trends...
Use this report to:
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.
Learn about the current state of pharmaceutical markets, and new drug development in the mental health segment, existing products on the market, and a detailed analysis of the competitive environments, including new potential markets and trends...
Use this report to:
- Gain a comprehensive view of the current state of the pharmaceutical marketplace, and new drug developments in the mental health segment
- Identify and evaluate new markets, trends, and developments in the mental health pharmaceutical industry, including potential new geographic markets and emerging products such as memory enhancement drugs
- Asses the competitive environment, the status and strategies of major market participants, and whether your company is appropriately positioned to capture market share
- Understand the drivers and challenges that affect growth and development in each submarket or category of psychiatric drugs.
To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.
RSS Feeds – Pharmaceuticals
GLOBAL MENTAL HEALTH PHARMACEUTICAL INDUSTRY BY DRUG CATEGORY, 2009-2015
($ BILLIONS)
Posts
No comments:
Post a Comment